What We're Reading: Page 295
Industry reads hand-picked by our editors
Jul 06, 2017
Jul 05, 2017
-
The Wall Street Journal
Why big pharma is targeting China’s deadliest diseases
-
Reuters
Drugmaker Shire faces blood and guts battles on road to growth
-
Financial Times
Fears over a medical gold rush in cancer drug race
Jun 30, 2017
Jun 29, 2017
-
Nikkei Asian Review
Takeda chief confronts growing pains – and lack of growth – without old ally
-
Kaiser Health News
Seniors miss out on clinical trials
-
MIT Technology Review
Organoids proposed to screen patients for high-priced drugs
Jun 28, 2017
-
The Washington Post
Pharmaceutical giant rocked by ransomware attack
-
CNBC
Teva Pharmaceutical CEO says health-care is facing 'huge disruption'
-
Scientific American
Human Cell Atlas opens a new window to health and disease
Jun 27, 2017
Jun 26, 2017
-
The Wall Street Journal
How AI is transforming drug creation
-
The Irish Times
Pharma research firm APC has just the right medicine
-
Phys.org
How to train your drugs: from nanotherapeutics to nanobots